Counteract

Description

The provided data does not include specific details regarding the chemical name, physical characteristics, or inactive ingredients of the drug. As such, a comprehensive description cannot be formulated. Further information is required to accurately convey the drug's properties and characteristics.

Uses and Indications

This drug is indicated for the temporary relief of minor aches and pains associated with various conditions, including headache, muscular aches, minor pain of arthritis, toothache, backache, the common cold, and menstrual cramps. Additionally, it is indicated for the temporary reduction of fever.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

Patients should adhere strictly to the recommended dosage and administration guidelines. The smallest effective dose should be utilized, and no more than the directed amount should be taken.

For adults and children aged 12 years and older, the recommended dosage is 1 tablet every 4 to 6 hours as needed while symptoms persist. If pain or fever does not adequately respond to 1 tablet, a maximum of 2 tablets may be taken. However, the total dosage must not exceed 6 tablets within a 24-hour period unless specifically directed by a healthcare professional.

For children under 12 years of age, it is advised to consult a doctor for appropriate dosing recommendations.

Contraindications

Use is contraindicated in patients with a history of allergic reactions to any other pain reliever or fever reducer. Additionally, the product should not be administered immediately before or after heart surgery due to potential complications associated with surgical recovery.

Warnings and Precautions

TAMPER EVIDENT: The product must not be used if the safety seal under the cap is broken or missing, as this indicates potential tampering.

General precautions should be observed to ensure safe use of the product. It is imperative to keep the medication out of reach of children to prevent accidental ingestion. In the event of an overdose, immediate medical assistance should be sought by contacting a Poison Control Center at 1-800-222-1222. The product is contraindicated in individuals with a history of allergic reactions to any other pain reliever or fever reducer. Additionally, it should not be used immediately before or after heart surgery due to potential complications.

Healthcare professionals should advise patients to discontinue use and seek medical attention if any of the following symptoms occur: signs of bleeding such as feeling faint, vomiting blood, having blood or black stools, or experiencing persistent stomach pain; if pain worsens or lasts longer than 10 days; if fever intensifies or persists beyond 3 days; if redness or swelling occurs in the affected area; or if any new symptoms arise.

Side Effects

Patients should be aware of the potential adverse reactions associated with the use of this medication. A boxed warning indicates that the product should not be used if the tamper-evident safety seal under the cap is broken or missing.

In clinical practice, patients are advised to stop using the medication and consult a doctor if they experience any signs of bleeding, which may include feeling faint, vomiting blood, having blood or black stools, or experiencing stomach pain that does not improve. Additionally, if pain worsens or persists for more than 10 days, if fever intensifies or lasts more than 3 days, if redness or swelling occurs in the painful area, or if any new symptoms appear, medical advice should be sought.

Before using this medication, patients should consult a doctor if they have a history of serious side effects from pain relievers or fever reducers, if the stomach bleeding warning is applicable, or if they have a history of stomach problems such as heartburn. Those with high blood pressure, heart disease, liver cirrhosis, or kidney disease, as well as individuals with asthma or those taking diuretics, should also seek medical advice prior to use.

Furthermore, patients should ask a doctor or pharmacist before using this medication if they are taking aspirin for heart attack or stroke, as ibuprofen may diminish the cardioprotective effects of aspirin. It is also important for patients under a doctor's care for any serious condition, those taking any other medications, those using other NSAIDs (whether prescription or nonprescription), or those on blood thinners (anticoagulants) or steroid drugs to consult a healthcare professional before use.

Drug Interactions

Ibuprofen may diminish the cardioprotective effects of aspirin when used for the prevention of heart attack or stroke. Therefore, it is advisable to avoid concurrent use of ibuprofen with aspirin in patients who are taking aspirin for these indications.

Caution is warranted when ibuprofen is administered alongside other medications, particularly those within the following categories:

Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)

The concomitant use of ibuprofen with other NSAIDs, whether prescription or over-the-counter, may increase the risk of adverse effects, including gastrointestinal bleeding and renal impairment. It is recommended to avoid the use of multiple NSAIDs simultaneously.

Anticoagulants

The use of ibuprofen in conjunction with anticoagulant medications may heighten the risk of bleeding. Close monitoring of patients on both ibuprofen and anticoagulants is advised to ensure safety and efficacy.

Corticosteroids

Co-administration of ibuprofen with steroid drugs may also elevate the risk of gastrointestinal complications. Healthcare providers should consider this interaction and monitor patients accordingly.

Patients are encouraged to consult with a healthcare professional, such as a doctor or pharmacist, prior to initiating ibuprofen if they are currently taking any other medications. This will help to ensure safe and effective use of ibuprofen while minimizing the risk of potential drug interactions.

Packaging & NDC

Below are the non-prescription pack sizes of Counteract (ibuprofen). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients under 12 years of age should consult a healthcare professional before use. For adolescents and adults aged 12 years and older, the recommended dosage is 1 tablet every 4 to 6 hours as needed for symptom relief. If pain or fever does not adequately respond to 1 tablet, a maximum of 2 tablets may be administered. It is important not to exceed 6 tablets within a 24-hour period unless directed by a healthcare provider.

This medication should be kept out of reach of children. In the event of an overdose, immediate medical assistance should be sought, or contact a Poison Control Center at 1-800-222-1222.

Geriatric Use

Elderly patients may have specific considerations when using this medication, although no specific geriatric use information is provided in the prescribing insert. It is advisable for healthcare providers to exercise caution and consider the following general warnings applicable to this population.

Before initiating treatment, elderly patients should consult with their healthcare provider if they have a history of high blood pressure, heart disease, liver cirrhosis, or kidney disease. These conditions may increase the risk of adverse effects associated with the medication.

Additionally, long-term continuous use of this medication may elevate the risk of serious cardiovascular events, such as heart attack or stroke, which is particularly pertinent for geriatric patients who may already be at an increased risk for these conditions.

Given the potential for heightened sensitivity to side effects in elderly patients, it is recommended that the smallest effective dose be utilized. This approach may help mitigate the risk of adverse reactions and ensure safer management of their health conditions. Regular monitoring and assessment of the patient's response to therapy are also advised to optimize treatment outcomes in this demographic.

Pregnancy

Pregnant patients and those who are breastfeeding should consult a healthcare professional before using this medication. It is particularly important to avoid the use of Ibuprofen during the last trimester of pregnancy unless specifically directed by a physician, as it may pose risks to the developing fetus and lead to complications during delivery.

Lactation

Lactating mothers are advised to consult a health professional before using this medication while breastfeeding. It is particularly important to avoid the use of Ibuprofen during the last three months of pregnancy unless explicitly directed by a healthcare provider, as it may pose risks to the unborn child or lead to complications during delivery. There is no specific data provided regarding the excretion of Ibuprofen in breast milk or its effects on breastfed infants. Therefore, healthcare providers should weigh the potential benefits against any risks when considering the use of this medication in lactating mothers.

Renal Impairment

There is no specific information available regarding dosage adjustments, special monitoring, or safety considerations for patients with renal impairment. Healthcare professionals should exercise caution when prescribing to patients with reduced kidney function, as the absence of detailed guidance necessitates careful clinical judgment. Regular monitoring of renal function may be advisable in this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific information regarding overdosage in the provided sections of the Summary of Product Characteristics (SPL), healthcare professionals are advised to exercise caution and consider general principles of management for suspected overdosage.

Recommended Actions In cases of suspected overdosage, it is essential for healthcare providers to assess the patient's clinical status promptly. Monitoring vital signs and conducting a thorough evaluation of symptoms is crucial. If an overdosage is suspected, supportive care should be initiated immediately.

Potential Symptoms While specific symptoms related to overdosage are not detailed, healthcare professionals should remain vigilant for any unusual or severe reactions that may arise. Symptoms may vary based on the pharmacological profile of the substance involved and the individual patient's response.

Management Procedures Management of overdosage should be tailored to the individual patient and may include symptomatic treatment and supportive measures. In the absence of specific antidotes or treatment protocols, healthcare providers should consult relevant toxicology resources or poison control centers for guidance on managing potential overdosage scenarios effectively.

In summary, due to the lack of specific overdosage information, healthcare professionals are encouraged to apply general overdosage management principles and remain alert to the clinical presentation of affected patients.

Nonclinical Toxicology

It is especially important not to use Ibuprofen during the last three months of pregnancy unless definitely directed to do so by a doctor, as it may cause problems in the unborn child or complications during delivery. No non-teratogenic effects have been specified in the available data. Additionally, there are no details provided regarding nonclinical toxicology or animal pharmacology and toxicology.

Postmarketing Experience

Long-term continuous use of the product has been associated with an increased risk of heart attack or stroke, as reported in postmarketing surveillance and voluntary reports. These findings highlight the importance of monitoring patients who are on prolonged therapy.

Patient Counseling

Healthcare providers should advise patients to keep this medication out of reach of children to prevent accidental ingestion. In the event of an overdose, patients should be instructed to seek medical help or contact a Poison Control Center immediately at 1-800-222-1222.

Patients must be cautioned against using this medication if they have ever experienced an allergic reaction to any other pain reliever or fever reducer. Additionally, it should not be used right before or after heart surgery.

Patients should be informed to stop using the medication and consult a doctor if they experience any signs of bleeding, such as feeling faint, vomiting blood, having blood or black stools, or experiencing stomach pain that does not improve. They should also be advised to seek medical attention if their pain worsens or persists for more than 10 days, if their fever worsens or lasts more than 3 days, if there is redness or swelling in the painful area, or if any new symptoms arise.

When using this product, patients should be encouraged to take it with food or milk if they experience stomach upset. It is important to inform patients that long-term continuous use may increase the risk of heart attack or stroke.

Patients should be advised to consult a doctor before using this medication if they have a history of problems or serious side effects from taking pain relievers or fever reducers, or if the stomach bleeding warning applies to them. They should also seek medical advice if they have a history of stomach problems such as heartburn, high blood pressure, heart disease, liver cirrhosis, or kidney disease, or if they have asthma.

Furthermore, patients should be instructed to consult a doctor before use if they are taking a diuretic, any other drug, or if they are under a doctor's care for any serious condition. It is also essential for patients to discuss with their doctor or pharmacist if they are taking aspirin for heart attack or stroke, as ibuprofen may diminish the benefits of aspirin. Lastly, patients should be reminded to inform their healthcare provider if they are taking any other drug containing an NSAID, a blood-thinning (anticoagulant) drug, or a steroid.

Storage and Handling

The product is supplied in various package configurations, with specific NDC numbers available for identification. It is essential to store the product at a controlled temperature range of 20 to 25°C (68 to 77°F) to maintain its efficacy and stability. Proper container requirements should be adhered to, ensuring that the product is kept in its original packaging to prevent exposure to environmental factors. Special handling needs should be observed to avoid any conditions that may compromise the integrity of the product.

Additional Clinical Information

Patients aged 12 years and older are advised to take one tablet of the medication orally every 4 to 6 hours while symptoms persist. If pain or fever does not adequately respond to one tablet, two tablets may be taken. However, the total dosage should not exceed six tablets in a 24-hour period unless directed by a healthcare professional. For children under 12 years, consultation with a doctor is recommended prior to administration.

Clinicians should counsel patients to seek advice from a health professional if they are pregnant or breastfeeding, particularly emphasizing the importance of avoiding the use of Ibuprofen during the last trimester of pregnancy unless specifically instructed by a doctor, due to potential risks to the unborn child or complications during delivery. Additionally, it is crucial to keep the medication out of reach of children and to seek immediate medical assistance or contact a Poison Control Center in the event of an overdose.

Drug Information (PDF)

This file contains official product information for Counteract, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)